BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 40 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $149,000 | +140.3% | 13,333 | 0.0% | 0.00% | – |
| Q1 2020 | $62,000 | +8.8% | 13,333 | 0.0% | 0.00% | – |
| Q4 2019 | $57,000 | +9.6% | 13,333 | 0.0% | 0.00% | – |
| Q3 2019 | $52,000 | -1.9% | 13,333 | 0.0% | 0.00% | – |
| Q2 2019 | $53,000 | -8.6% | 13,333 | 0.0% | 0.00% | – |
| Q1 2019 | $58,000 | +23.4% | 13,333 | 0.0% | 0.00% | – |
| Q4 2018 | $47,000 | -7.8% | 13,333 | 0.0% | 0.00% | – |
| Q3 2018 | $51,000 | -1.9% | 13,333 | 0.0% | 0.00% | – |
| Q2 2018 | $52,000 | +23.8% | 13,333 | 0.0% | 0.00% | – |
| Q1 2018 | $42,000 | -19.2% | 13,333 | 0.0% | 0.00% | – |
| Q4 2017 | $52,000 | -5.5% | 13,333 | 0.0% | 0.00% | – |
| Q3 2017 | $55,000 | 0.0% | 13,333 | 0.0% | 0.00% | – |
| Q2 2017 | $55,000 | -3.5% | 13,333 | 0.0% | 0.00% | – |
| Q1 2017 | $57,000 | +67.6% | 13,333 | 0.0% | 0.00% | – |
| Q4 2016 | $34,000 | +6.2% | 13,333 | 0.0% | 0.00% | – |
| Q3 2016 | $32,000 | 0.0% | 13,333 | 0.0% | 0.00% | – |
| Q2 2016 | $32,000 | -11.1% | 13,333 | 0.0% | 0.00% | – |
| Q1 2016 | $36,000 | -5.3% | 13,333 | 0.0% | 0.00% | – |
| Q4 2015 | $38,000 | +22.6% | 13,333 | 0.0% | 0.00% | – |
| Q3 2015 | $31,000 | -35.4% | 13,333 | 0.0% | 0.00% | – |
| Q2 2015 | $48,000 | -53.8% | 13,333 | -42.9% | 0.00% | -100.0% |
| Q1 2015 | $104,000 | -6.3% | 23,333 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $111,000 | – | 23,333 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 242,850 | $923,000 | 0.13% |
| ABNER HERRMAN & BROCK LLC | 241,500 | $918,000 | 0.13% |
| Weaver Consulting Group | 48,881 | $186,000 | 0.10% |
| Tibra Equities Europe Ltd | 87,000 | $331,000 | 0.10% |
| Ikarian Capital, LLC | 293,200 | $1,115,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 60,238 | $229,000 | 0.03% |
| Ergoteles LLC | 124,329 | $472,000 | 0.01% |
| CFO4Life Group, LLC | 12,003 | $46,000 | 0.01% |
| HighPoint Advisor Group LLC | 17,033 | $65,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 32,836 | $125,000 | 0.00% |